Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Jan. 12, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is M ylan Pharmaceuticals Inc., and Mylan Inc.’s Motion to Compel , Dkt. No. 210. The Mylan defendants (“Mylan”) ask the Court to order plaintiff Allergan, Inc., to produce a settlement agreement between Allergan and Apotex ( formally, Apotex Corp. and Apotex Inc.), one of the generic drug manufacturers initially sued by Allergan in this case. The Court GRANTS the motion to compel and directs that the agreement be produced on an Outside Counsel’s Eyes Only basis.